Follistatin-like protein 1 modulates IL-17 signaling via IL-17RC regulation in stromal cells. Campfield BT, Eddens T, Henkel M, Majewski M, Horne W, Chaly Y, Gaffen SL, Hirsch R, Kolls JK. Immunol Cell Biol. 2017 Sep;95(8):656-665. doi: 10.1038/icb.2017.26. Epub 2017 Apr 5.
Antiinflammatory effects of bromodomain and extraterminal domain inhibition in cystic fibrosis lung inflammation. Chen K, Campfield BT, Wenzel SE, McAleer JP, Kreindler JL, Kurland G, Gopal R, Wang T, Chen W, Eddens T, Quinn KM, Myerburg MM, Horne WT, Lora JM, Albrecht BK, Pilewski JM, Kolls JK. JCI Insight. 2016 Jul 21;1(11). pii: e87168.
A Novel CD4+ T Cell-Dependent Murine Model of Pneumocystis-driven Asthma-like Pathology. Eddens T, Campfield BT, Serody K, Manni ML, Horne W, Elsegeiny W, McHugh KJ, Pociask D, Chen K, Zheng M, Alcorn JF, Wenzel S, Kolls JK. Am J Respir Crit Care Med. 2016 Oct 1;194(7):807-820.
Follistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection. Campfield BT, Nolder CL, Marinov A, Bushnell D, Davis A, Spychala C, Hirsch R, Nowalk AJ. Microb Pathog. 2014 Aug;73:70-9. doi: 10.1016/j.micpath.2014.04.005. Epub 2014 Apr 24.
Vaccine approaches for multidrug resistant Gram negative infections. Campfield B, Chen K, Kolls JK. Curr Opin Immunol. 2014 Jun;28:84-9. doi: 10.1016/j.coi.2014.02.002. Epub 2014 Mar 15.